PHOSPHOLIPID ANTITUMOR AGENTS

被引：118

作者：

HOULIHAN, WJ

LOHMEYER, M

WORKMAN, P

CHEON, SH

机构：

[1] UNIV GLASGOW,CRC,BEATSON LABS,DEPT MED ONCOL,GLASGOW G61 1BD,LANARK,SCOTLAND

[2] SANDOZ PHARMACEUT CORP,SANDOZ RES INST,PRECLIN RES,DEPT DIABET,E HANOVER,NJ 07936

来源：

MEDICINAL RESEARCH REVIEWS | 1995年 / 15卷 / 03期

关键词：

D O I：

10.1002/med.2610150302

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：157 / 223

页数：67

共 560 条

[1]

ALUNNIBISTOCCHI G, 1990, FARMACO, V45, P499

[2]

ANDREESEN R, 1979, Immunobiology, V156, P255

[3] DIFFERENTIAL-EFFECTS OF ETHER LIPIDS ON THE ACTIVITY AND SECRETION OF INTERLEUKIN-1 AND INTERLEUKIN-2 [J].

ANDREESEN, R ;

GIESE, V .

LIPIDS, 1987, 22 (11) :836-841

[4]

ANDREESEN R, 1982, ANTICANCER RES, V2, P95

[5]

Andreesen R, 1988, Prog Biochem Pharmacol, V22, P118

[6]

ANDREESEN R, 1983, EXP HEMATOL, V11, P564

[7] TUMOR CYTO-TOXICITY OF HUMAN MACROPHAGES AFTER INCUBATION WITH SYNTHETIC ANALOGS OF 2-LYSOPHOSPHATIDYLCHOLINE [J].

ANDREESEN, R ;

OSTERHOLZ, J ;

LUCKENBACH, GA ;

COSTABEL, U ;

SCHULZ, A ;

SPETH, V ;

MUNDER, PG ;

LOHR, GW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1984, 72 (01) :53-59

[8]

ANDREESEN R, 1988, PLATELET ACTIVATING, V4, P16

[9]

ARAI Y, 1984, Patent No. 109255

[10]

ARAI Y, 1985, Patent No. 145303

← 1 2 3 4 5 6 7 8 9 10 →